Join to View Full Profile
1100 Fairview Ave. NSeattle, WA 98109
Dr. Tuazon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2018
Albert Einstein Healthcare NetworkResidency, Internal Medicine, 2009 - 2012
University of Santo TomasClass of 2006
Certifications & Licensure
WA State Medical License 2016 - 2026
PA State Medical License 2009 - 2016
VA State Medical License 2014 - 2016
Awards, Honors, & Recognition
- Magna cum laude University of Santo Tomas Faculty of Medicine and Surgery, 2006
Publications & Presentations
PubMed
- Impact of Gamma-Secretase Inhibition on Outcomes Following BCMA CAR-T Therapy in Multiple Myeloma: A Comparison of Two Phase 1 Trials.Andrew J Portuguese, Sherilyn A Tuazon, Margot J Pont, Gabriel O Cole, Blythe D Sather
Transplantation and Cellular Therapy. 2025-09-08 - 1 citationsA phase 1 trial of fully human BCMA CAR-T therapy for relapsed/refractory multiple myeloma with 5-year follow-up.Sherilyn A Tuazon, Andrew J Portuguese, Margot J Pont, Andrew J Cowan, Gabriel O Cole
Blood. 2025-07-31 - 4 citationsAcquired CD38 gene deletion as a mechanism of tumor antigen escape in multiple myeloma.Andrew J Portuguese, Min Fang, Sherilyn A Tuazon, Margot Pont, Xiaoyu Qu
Blood Advances. 2023-12-12
Abstracts/Posters
- Efficacy and Safety of Fully Human Bcma CAR T Cells in Combination with a Gamma Secretase Inhibitor to Increase Bcma Surface Expression in Patients with Relapsed or Re...Sherilyn A. Tuazon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- The Alpha Emitter Astatine-211 Targeted to CD38 Can Eradicate Multiple Myeloma in Minimal Residual Disease Models2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Prolonged Lenalidomide Therapy in Multiple Myeloma Patients Does Not Impact Autologous PBSC Mobilization: A Single Center Retrospective Analysis2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Professional Memberships
- Associate
- Member
- Member
- American Society for Blood and Marrow TransplantationMember
- European Society for Medical OncologyMember
Other Languages
- Filipino
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
